FDA Import Refusal AEK-7231643-1/102/1 — Novo Nordisk
The FDA refused shipment AEK-7231643-1/102/1 from Novo Nordisk (India) on Jun 30, 2025. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 30, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDL17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75